Cobas 4800 BRAF V600 Mutation Test regulatory update

Roche said Health Canada approved its cobas 4800 BRAF V600 Mutation Test to identify patients with metastatic melanoma tumors with a mutation in the BRAF gene. The PCR-based nucleic acid test detects ...